Targeting inflammation in endometriosis: emerging therapeutic options.
Endometriosis is a chronic, estrogen-dependent inflammatory disease affecting up to 10% of reproductive-aged women. Current therapies are predominantly hormone-based and offer symptomatic relief without correcting the immune dysregulation and inflammation …
Endometriosis as an immune-mediated disease: pathogenetic mechanisms and therapeutic strategies.
Endometriosis, which affects approximately 10% of women of reproductive age, is a complex inflammatory disease with significant immune system disturbances caused by an inadequate immune response to retrograde menstruation and …
Ovarian squamous cell carcinoma: clinicopathological features, prognosis and immunotherapy outcomes.
To explore the characteristics and survival outcomes of ovarian squamous cell carcinoma (SCC) and the treatment effectiveness of immune checkpoint inhibitors (ICIs).